General Information of the Compound
Compound ID
CP0481717
Compound Name
Elidel
    Show/Hide
Synonyms
33-epi-Chloro-33-desoxyascomycin
ASM 981
ASM-981
ASM-998
Elidel
Elidel (TN)
Pimecrolimus
Pimecrolimus (JAN/USAN/INN)
Pimecrolimus [USAN:INN:BAN]
SDZ ASM 981
SDZ-ASM 981
SDZ-ASM-981
    Show/Hide
Structure
Formula
C43H68ClNO11
Molecular Weight
810.466
Canonical SMILES
CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC
    Show/Hide
InChI
InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1
    Show/Hide
InChIKey
KASDHRXLYQOAKZ-XDSKOBMDSA-N
CAS
137071-32-0
Physicochemical Property
logP
5.7194
Rotatable Bonds
6
Heavy Atom Count
56
Polar Areas
158.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
11
Complexity
56

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6509979
SID: 12014634
ChEMBL ID
CHEMBL1200686
DrugBank ID
DB00337
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04542, Bile salt export pump
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Pimecrolimus )
Drug Name Pimecrolimus
Company Norvatis Phamaceuticals Corporation
Indication
Atopic dermatitis
Approved
Target(s)
Calcineurin (PPP3CA)
Inhibitor